In addition, the increased expression and activity of PLCβ1 mediated by neuropeptide agonists suggests that PLCβ1 can induce the stimulation of neuroendocrine growth factors that support the progression of SCLC. This evidence concerns the gene PLCB1 and small cell lung carcinoma.